MGNX Relative Valuation
MGNX's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, MGNX is overvalued; if below, it's undervalued.
Historical Valuation
MacroGenics Inc (MGNX) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -3.50. The fair price of MacroGenics Inc (MGNX) is between NaN to NaN according to relative valuation methord.
Relative Value
Fair Zone
NaN-NaN
Current Price：1.38
Fair
-0.64
PE
1Y
3Y
5Y
Trailing
Forward
0.00
EV/EBITDA
MacroGenics Inc. (MGNX) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is -3.21. The thresholds are as follows: Strongly Undervalued below -10.98, Undervalued between -10.98 and -7.10, Fairly Valued between 0.67 and -7.10, Overvalued between 0.67 and 4.55, and Strongly Overvalued above 4.55. The current Forward EV/EBITDA of 0.00 falls within the Historic Trend Line -Fairly Valued range.
0.13
EV/EBIT
MacroGenics Inc. (MGNX) has a current EV/EBIT of 0.13. The 5-year average EV/EBIT is -2.87. The thresholds are as follows: Strongly Undervalued below -8.84, Undervalued between -8.84 and -5.86, Fairly Valued between 0.12 and -5.86, Overvalued between 0.12 and 3.11, and Strongly Overvalued above 3.11. The current Forward EV/EBIT of 0.13 falls within the Overvalued range.
1.59
PS
MacroGenics Inc. (MGNX) has a current PS of 1.59. The 5-year average PS is 5.07. The thresholds are as follows: Strongly Undervalued below -3.55, Undervalued between -3.55 and 0.76, Fairly Valued between 9.38 and 0.76, Overvalued between 9.38 and 13.68, and Strongly Overvalued above 13.68. The current Forward PS of 1.59 falls within the Historic Trend Line -Fairly Valued range.
-0.99
P/OCF
MacroGenics Inc. (MGNX) has a current P/OCF of -0.99. The 5-year average P/OCF is -5.50. The thresholds are as follows: Strongly Undervalued below -33.49, Undervalued between -33.49 and -19.49, Fairly Valued between 8.50 and -19.49, Overvalued between 8.50 and 22.50, and Strongly Overvalued above 22.50. The current Forward P/OCF of -0.99 falls within the Historic Trend Line -Fairly Valued range.
-0.83
P/FCF
MacroGenics Inc. (MGNX) has a current P/FCF of -0.83. The 5-year average P/FCF is -5.92. The thresholds are as follows: Strongly Undervalued below -17.49, Undervalued between -17.49 and -11.70, Fairly Valued between -0.13 and -11.70, Overvalued between -0.13 and 5.65, and Strongly Overvalued above 5.65. The current Forward P/FCF of -0.83 falls within the Historic Trend Line -Fairly Valued range.
MacroGenics Inc (MGNX) has a current Price-to-Book (P/B) ratio of 1.30. Compared to its 3-year average P/B ratio of 2.94 , the current P/B ratio is approximately -55.70% higher. Relative to its 5-year average P/B ratio of 3.15, the current P/B ratio is about -58.61% higher. MacroGenics Inc (MGNX) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of -42.29%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of -37.68% , the current FCF yield is about -100.00% lower.
1.30
P/B
Median3y
2.94
Median5y
3.15
-186.04
FCF Yield
Median3y
-42.29
Median5y
-37.68
Competitors Valuation Multiple
The average P/S ratio for MGNX's competitors is 0.00, providing a benchmark for relative valuation. MacroGenics Inc Corp (MGNX) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of -34.21%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of MGNX decreased by 57.54% over the past 1 year. The primary factor behind the change was an decrease in P/E Change from -0.87 to -1.14.
The secondary factor is the Revenue Growth, contributed -34.21%to the performance.
Overall, the performance of MGNX in the past 1 year is driven by P/E Change. Which is more unsustainable.
People Also Watch
FAQ
Is MacroGenics Inc (MGNX) currently overvalued or undervalued?
What is MacroGenics Inc (MGNX) fair value?
How does MGNX's valuation metrics compare to the industry average?
What is the current P/B ratio for MacroGenics Inc (MGNX) as of Dec 05 2025?
What is the current FCF Yield for MacroGenics Inc (MGNX) as of Dec 05 2025?
What is the current Forward P/E ratio for MacroGenics Inc (MGNX) as of Dec 05 2025?